×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Is Sareum Holdings (LON:SAR) In A Good Position To Invest In Growth?
Yahoo News New Zealand
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
5 days ago
Sareum (LON:SAR) Trading Down 5.7%
Defense World
Sareum Holdings plc (LON:SAR – Get Free Report) dropped 5.7% on Friday . The stock traded as low as GBX 35.13 ($0.44) and last traded at GBX...
23 hours ago
Sareum Holdings Announces Warrant Exercise and Share Issue - TipRanks.com
Tipranks
Sareum Holdings (GB:SAR) has released an update. Sareum Holdings PLC, a biotech firm specializing in kinase inhibitors for cancer and autoimmune diseases,...
2 weeks ago
Market Sentiment Around Loss-Making Sareum Holdings plc (LON:SAR)
Simply Wall Street
Sareum Holdings is bordering on breakeven, according to the 2 British Pharmaceuticals analysts. They anticipate the company to incur a final...
2 months ago
We're Not Very Worried About Sareum Holdings' (LON:SAR) Cash Burn Rate
Yahoo
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
2 days ago
Sareum doses first subjects in second stage of Phase 1a trial of SDC-1801
Clinical Trials Arena
Sareum has dosed the first subjects in the multiple ascending dose section of a Phase Ia trial of SDC-1801 to treat autoimmune disease.
8 months ago
Sareum partner CPF inks deal to out-license SRA737
The Pharma Letter
UK-based biotech Sareum Holdings (AIM: SAR) saw its shares gain 18% to 70.00 pence by early afternoon after it announced that is...
4 months ago
Sareum says so long to SAD and hi to happy as trials hurdle is cleared
Business Weekly
Cambridge biotech company Sareum Holdings plc has sailed through an import element of a Phase 1a clinical trial for its lead programme.
3 months ago
Sareum shares jump on cancer drug licensing deal
Sharecast.com
Shares in AIM-listed biotech group Sareum jumped by a fifth on Tuesday after its co-development partner for cancer treatment SRA737 signed a...
4 months ago
Sareum Holdings Repeat Insider Selling Not A Positive Indicator
Simply Wall St
Sareum Holdings Repeat Insider Selling Not A Positive Indicator ... Sareum Holdings plc (LON:SAR) shareholders might have a reason to worry after...
5 months ago